NCT01088386View on ClinicalTrials.gov

Zyprexa® Relprevv™ Patient Care Program

Enrolling by invitationOBSERVATIONAL
Enrollment

4,000

Participants

Timeline

Start Date

March 3, 2010

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Schizophrenia
Trial Locations (1)

19422

United BioSource Corporation, Blue Bell

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01088386 - Zyprexa® Relprevv™ Patient Care Program | Biotech Hunter | Biotech Hunter